Multinational monkeypox outbreak: what do we know and what should we do? (Jun, 10.1007/s11845-022-03052-4, 2022)

被引：2
|
作者：
Memariani, Mojtaba [1 ,2 ]
Memariani, Hamed [1 ,3 ]
机构：
[1] Shahid Beheshti Univ Med Sci, Skin Res Ctr, Tehran, Iran
[2] Univ Tehran Med Sci, Sch Publ Hlth, Dept Pathobiol, Tehran, Iran
[3] Pasteur Inst Iran, Biotechnol Res Ctr, Tehran, Iran
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2023年 / 192卷 / 02期
关键词：
D O I：
10.1007/s11845-022-03064-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：971 / 971
页数：1
相关论文
共 50 条
  • [21] Alcohol and cardiovascular disease; What do we know? What should we do?
    Trevisan, M
    Dorn, J
    [J]. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1996, 6 (03) : 111 - 113
  • [22] Investigating the monkeypox outbreak Here's what we know, and what we need to know
    Dye, Christopher
    Kraemer, Moritz U. G.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2022, 377
  • [23] Cannabis and Breastfeeding: What We Know and What We Should Do
    Kendall-Tackett, Kathleen
    [J]. CLINICAL LACTATION, 2020, 11 (03) : 117 - 120
  • [24] Facing the COVID-19 outbreak: What should we know and what could we do?
    Yang, Yi
    Shang, Weilong
    Rao, Xiancai
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (06) : 536 - 537
  • [25] PUBLIC MANAGEMENT - WHAT DO WE KNOW - WHAT SHOULD WE KNOW - AND HOW WILL WE KNOW IT
    LYNN, LE
    [J]. JOURNAL OF POLICY ANALYSIS AND MANAGEMENT, 1987, 7 (01) : 178 - 187
  • [26] What We Know About Monkeypox and What We Need to Do to Protect Ourselves!
    Nalca, Ayseguel
    [J]. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY, 2022, 4 (03): : 218 - 220
  • [27] Neuropsychiatric adverse effects of mefloquine - What do we know and what should we do?
    Nosten, F
    van Vugt, M
    [J]. CNS DRUGS, 1999, 11 (01) : 1 - 8
  • [28] WHAT DO WE KNOW AND WHAT SHOULD WE DO ABOUT NUTRITION EDUCATION FOR ADOLESCENTS
    CARRUTH, BR
    SKINNER, JD
    [J]. JOURNAL OF NUTRITION EDUCATION, 1988, 20 (06): : 271 - 272
  • [29] Merkel cell carcinoma: What do we know about it and what should we do?
    Prieto Munoz, Isabel
    Pardo Masferrer, Jose
    Olivera Vegas, Jesus
    Fortes Alen, Jose Ramon
    Perez Casas, Ana M.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2012, 14 (06): : 401 - 412
  • [30] Glucose lowering and cardiovascular disease: what do we know and what should we do?
    Cheng, Alice Y. Y.
    Leiter, Lawrence A.
    [J]. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2010, 17 : S25 - S31
12345